Enovis EBITDA Margin 2010-2024 | ENOV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Enovis (ENOV) over the last 10 years. The current EBITDA margin for Enovis as of September 30, 2024 is .
Enovis EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2024-09-30 |
$2.00B |
$0.15B |
7.50% |
2024-06-30 |
$1.91B |
$0.15B |
7.63% |
2024-03-31 |
$1.82B |
$0.16B |
8.97% |
2023-12-31 |
$1.71B |
$0.15B |
8.90% |
2023-09-30 |
$1.66B |
$0.13B |
7.52% |
2023-06-30 |
$1.63B |
$0.12B |
7.49% |
2023-03-31 |
$1.59B |
$0.14B |
8.78% |
2022-12-31 |
$1.56B |
$0.15B |
9.47% |
2022-09-30 |
$0.99B |
$0.09B |
9.34% |
2022-06-30 |
$0.96B |
$0.11B |
11.76% |
2022-03-31 |
$0.92B |
$0.11B |
12.15% |
2021-12-31 |
$1.43B |
$0.20B |
14.10% |
2021-09-30 |
$0.47B |
$0.13B |
27.06% |
2021-06-30 |
$0.92B |
$0.20B |
21.55% |
2021-03-31 |
$1.18B |
$0.20B |
16.82% |
2020-12-31 |
$1.12B |
$0.18B |
16.07% |
2020-09-30 |
$3.13B |
$0.42B |
13.48% |
2020-06-30 |
$3.17B |
$0.44B |
13.78% |
2020-03-31 |
$3.46B |
$0.50B |
14.36% |
2019-12-31 |
$3.33B |
$0.44B |
13.19% |
2019-09-30 |
$2.67B |
$0.35B |
13.09% |
2019-06-30 |
$2.34B |
$0.29B |
12.16% |
2019-03-31 |
$2.00B |
$0.25B |
12.42% |
2018-12-31 |
$2.19B |
$0.30B |
13.68% |
2018-09-30 |
$1.48B |
$0.40B |
26.95% |
2018-06-30 |
$1.80B |
$0.43B |
24.03% |
2018-03-31 |
$2.09B |
$0.46B |
22.01% |
2017-12-31 |
$1.94B |
$0.45B |
23.32% |
2017-09-30 |
$3.01B |
$0.40B |
13.28% |
2017-06-30 |
$2.93B |
$0.38B |
13.09% |
2017-03-31 |
$3.04B |
$0.39B |
12.68% |
2016-12-31 |
$3.19B |
$0.38B |
11.93% |
2016-09-30 |
$3.13B |
$0.38B |
12.04% |
2016-06-30 |
$3.33B |
$0.37B |
11.10% |
2016-03-31 |
$3.40B |
$0.39B |
11.53% |
2015-12-31 |
$3.43B |
$0.42B |
12.23% |
2015-09-30 |
$4.11B |
$0.48B |
11.75% |
2015-06-30 |
$4.31B |
$0.56B |
13.01% |
2015-03-31 |
$4.48B |
$0.58B |
12.95% |
2014-12-31 |
$4.62B |
$0.59B |
12.65% |
2014-09-30 |
$4.59B |
$0.58B |
12.73% |
2014-06-30 |
$4.44B |
$0.56B |
12.53% |
2014-03-31 |
$4.31B |
$0.54B |
12.56% |
2013-12-31 |
$4.21B |
$0.53B |
12.48% |
2013-09-30 |
$4.06B |
$0.46B |
11.25% |
2013-06-30 |
$4.00B |
$0.42B |
10.52% |
2013-03-31 |
$3.97B |
$0.39B |
9.76% |
2012-12-31 |
$3.91B |
$0.32B |
8.28% |
2012-09-30 |
$3.06B |
$0.24B |
7.73% |
2012-06-30 |
$2.28B |
$0.15B |
6.58% |
2012-03-31 |
$1.42B |
$0.07B |
4.93% |
2011-12-31 |
$0.69B |
$0.05B |
7.06% |
2011-09-30 |
$0.68B |
$0.08B |
11.27% |
2011-06-30 |
$0.65B |
$0.08B |
12.25% |
2011-03-31 |
$0.58B |
$0.06B |
11.02% |
2010-12-31 |
$0.54B |
$0.05B |
9.59% |
2010-09-30 |
$0.51B |
$0.04B |
8.10% |
2010-06-30 |
$0.50B |
$0.04B |
8.35% |
2010-03-31 |
$0.51B |
$0.05B |
8.84% |
2009-12-31 |
$0.53B |
$0.06B |
10.67% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$2.529B |
$1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|